It goes by the names of Wellbutrin®, Wellbutrin XL®, and Wellbutrin XR® – drugs frequently taken for depression. Also trading under the name Zyban is a stop-smoking aid.
Generically called Bupropion, a recent study showed a risk of having babies born with a heart birth defect. These are very serious side effects.
When will the FDA take action to alert patients and doctors about the study showing the link of Wellbutrin to heart defects? When will the FDA require GlaxoSmithKline to add a black box warning for the potential problem.
Perhaps this lack of action from the FDA will change with the new study from the American Journal of Obstetrics & Gynecology.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.